Effect of IL-1 beta and TNF-alpha on the expression of monocyte chemotactic protein-1 in endometriotic cells

Y Gao1, L Luo, F He

  • 1Department of Obstetrics and Gynecology, Xiehe Hospital, Tongji Medical University, Wuhan 430022.

Journal of Tongji Medical University = Tong Ji Yi Ke Da Xue Xue Bao
|July 5, 2003
PubMed

Insights

Interleukin-1 beta and Tumor Necrosis Factor-alpha significantly increase monocyte chemotactic protein-1 (MCP-1) in endometriosis cells. This suggests MCP-1 plays a role in endometriosis development.

Area of Science:

  • Reproductive Biology
  • Immunology
  • Cell Biology

Background:

  • Endometriosis is a condition where tissue similar to the lining inside the uterus grows outside the uterus.
  • Monocyte chemotactic protein-1 (MCP-1) is a key chemokine involved in inflammatory processes.

Purpose of the Study:

  • To investigate the clinical significance of monocyte chemotactic protein-1 (MCP-1) produced by endometriotic tissues.
  • To determine the effect of Interleukin-1 beta (IL-1 beta) and Tumor Necrosis Factor-alpha (TNF-alpha) on MCP-1 expression in endometriotic cells.

Main Methods:

  • Endometriotic tissues were obtained from 15 patients with endometriosis.
  • MCP-1 mRNA and protein levels were measured using dot blot analysis and ELISA.
  • Cells were cultured with or without IL-1 beta or TNF-alpha.

Main Results:

  • Exposure to IL-1 beta and TNF-alpha significantly upregulated MCP-1 mRNA expression in endometriotic cells compared to controls (P < 0.05).
  • MCP-1 protein levels were also significantly higher in cells treated with IL-1 beta and TNF-alpha than in the control group (P < 0.01).

Conclusions:

  • IL-1 beta and TNF-alpha can up-regulate MCP-1 expression in endometriotic cells.
  • The increased expression of MCP-1 may be associated with the pathogenesis and development of endometriosis.